A detailed history of Bay Bridge Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bay Bridge Capital Group, LLC holds 9,528 shares of PFE stock, worth $238,962. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,528
Previous 55,714 82.9%
Holding current value
$238,962
Previous $1.35 Billion 82.02%
% of portfolio
0.15%
Previous 0.87%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

SELL
$23.29 - $25.88 $1.08 Million - $1.2 Million
-46,186 Reduced 82.9%
9,528 $243 Million
Q2 2025

Jul 16, 2025

BUY
$21.59 - $24.84 $55,356 - $63,689
2,564 Added 4.82%
55,714 $1.35 Billion
Q1 2025

Apr 17, 2025

BUY
$25.01 - $27.13 $345,663 - $374,963
13,821 Added 35.14%
53,150 $1.35 Billion
Q4 2024

Jan 28, 2025

BUY
$24.8 - $30.19 $19,046 - $23,185
768 Added 1.99%
39,329 $1.04 Billion
Q3 2024

Oct 23, 2024

BUY
$27.7 - $31.39 $1.07 Million - $1.21 Million
38,561 New
38,561 $1.12 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bay Bridge Capital Group, LLC Portfolio

Follow Bay Bridge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Bridge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Bridge Capital Group, LLC with notifications on news.